🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer

mBio(2023)10.1128/mbio.00396-23Source: DataRank Database

Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer is a research paper published in mBio (2023). On theSindex it has a DataRank of 0.416. It has been cited 15 times.

N/A

0.416DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (30 grants)Impact (FWCI 1.84)OA: goldTopics (57)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.416

From this paper's citation signal

Citation Network Contribution

0

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (12)

Lisa Beatrice Caruso ORCID,Chenhe Su,Kelsey Keith ORCID,Samantha S. Soldan ORCID,Davide Maestri

Live enrichment

PubMed:37606370 OpenAlex:https://openalex.org/W4386046541

HHS | NIH | National Cancer Institute

Grant: T32CA09171

HHS | NIH | National Cancer Institute

Grant: R50CA211199

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R01AI164709

HHS | NIH | National Cancer Institute

Grant: R01CA228700, U01CA275301, PO1CA269043

HHS | NIH | National Institute of Dental and Craniofacial Research

Grant: R01DE017336

HHS | NIH | National Cancer Institute

Grant: R01CA093606, P30CA010815, PO1CA269043, R01CA259171

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R01AI130209

HHS | NIH | National Cancer Institute

Grant: P30CA010815

HHS | NIH | National Institute of General Medical Sciences

Grant: R01GM124449

HHS | NIH | National Cancer Institute

Grant: PO1CA269043

National Institutes of Health

Grant: 5R01DE017336-12

Epigenetic Regulation of Epstein-Barr Virus

National Institutes of Health

Grant: 5R01CA259171-04

Drugging EBNA1 to Treat EBV-Associated Cancers

National Institutes of Health

Grant: 2T32CA009171-21

TRAINING PROGRAM IN BASIC CANCER RESEARCH

National Institutes of Health

Grant: 5R01CA093606-13

Regulation of EBV Latency by EBNA1

National Institutes of Health

Grant: 5R50CA211199-04

Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level

National Institutes of Health

Grant: 5P30CA010815-28

CONSOLIDATED BASIC CANCER RESEARCH PROGRAM

National Institutes of Health

Grant: 5U01CA275301-03

B cell determinants of EBV latency

National Institutes of Health

Grant: 5R01GM124449-03

Regulation of PRC2 functions by PARP1

National Institutes of Health

Grant: 7R01AI130209-04

Regulation of Viral Chromatin Architecture During EBV Latency

National Institutes of Health

Grant: 1R01CA228700-01A1

Epstein-Barr virus LMP1 mediated oncogenicity

National Institutes of Health

Grant: 5R01AI164709-05

Regulation of the Epstein-Barr Virus Lytic Switch

NCI NIH HHS

Grant: R01 CA259171

NCI NIH HHS

Grant: R01 CA093606

NIAID NIH HHS

Grant: R01 AI153506

NIAID NIH HHS

Grant: R01 AI155086

NCI NIH HHS

Grant: P01 CA269043

NIAID NIH HHS

Grant: R01 AI153508

NCI NIH HHS

Grant: T32 CA009171

NCI NIH HHS

Grant: R01 CA228700

NCI NIH HHS

Grant: U01 CA275301

FWCI

1.84

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.00396-23

publisherhttps://doi.org/10.1128/mbio.00396-23

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.00396-23

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37606370

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10653948

Fields of Study

Viral-associated cancers and disordersRNA modifications and cancerEpigenetics and DNA Methylation0301 basic medicine03 medical and health sciencesHumansChromatinHerpesvirus 4, HumanCCCTC-Binding FactorDNA MethylationEpstein-Barr Virus InfectionsDecitabineStomach NeoplasmsVirus LatencyDNAGenomicsBinding Sites

MeSH Terms

CCCTC-Binding FactorDecitabineBinding SitesChromatinDNAHerpesvirus 4, HumanHumansStomach NeoplasmsVirus LatencyDNA MethylationEpstein-Barr Virus InfectionsGenomics

Keywords

CTCFChromatinDecitabineDNA methylationLytic cycleGeneticsDNABiologyComputational biologyTranscription factorGeneGene expressionEnhancerVirusHerpesvirus 4, HumanCCCTC-Binding FactorEpstein-Barr Virus InfectionsBinding Sitesepigeneticsgastric cancerGenomicsMicrobiologyQR1-502Virus LatencyStomach NeoplasmsEpstein-Barr virusHumansResearch Article

Sustainable Development Goals

SDG 0: Good health and well-being